This Solicitation opportunity from Department Of Defense was posted on May 27, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
MILBEMYCIN OXIME AN
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This contract covers the procurement of MILBEMYCIN OXIME AND PRAZIQUANTEL chewable tablets intended for veterinary use in dogs weighing between 50.1 to 100 pounds, aged six weeks or older. Each tablet contains 23 mg of milbemycin oxime and 228 mg of praziquantel and is chicken flavored to encourage administration. The medication serves as a broad-spectrum parasiticide designed to prevent heartworm disease and to treat and control infections caused by adult roundworms, hookworms, whipworms, and tapeworms. The product is packaged in sets of five boxes, each containing 12 tablets, totaling 60 tablets per package, and is to be stored in its original closed container at controlled room temperature ranging from 15 to 25 degrees Celsius. The contract specifies detailed packaging and marking requirements in accordance with military standards and the Medical Marking Standard No. 1 to ensure protection during transport and compliance with regulatory guidelines. The shelf life of the drug is 24 months and is non-extendable. Delivery is set at 89 days FOB destination, with inspection and acceptance also at the destination point. The contract is issued through the Department of Defense's Medical Supply Chain Pharm FSA, with management and technical oversight ensuring adherence to FDA regulations and applicable quality standards. The point of contact for this procurement is available for coordination, and the delivery location is the US Military Medical Material Center in Europe.
General Info
Agency
NAICS
Place of Performance
ATTN CL VIII MED REQ PROCES ACT, APO, AE, 09227-0000, USSet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
MILBEMYCIN OXIME AND PRAZIQUANTEL TABLET,VETERINARY
.
23MG MILBEMYCIN OXIME & 228MG PRAZIQUANTEL; FOR USE IN
DOGS 50.1 TO 100 LBS AND 6 WEEKS OF AGE AND OLDER; CHICKEN FLAVORED
CHEWABLE TABLETS; BROAD-SPECTRUM PARASITICIDE:
PREVENTS HEARTWORM DISEASE TREATS AND CONTROLS ADULT ROUNDWORM,
HOOKWORM<(>,<)> WHIPWORM, AND TAPEWORM INFECTIONS. PACKAGE OF 5BX OF 12
TABLETS = TOTAL OF 60 TABLETS (5x12 DOSE). . UNIT OF ISSUE: PACKAGE (PG) OF 60EA . STORE IN CLOSED ORIGINAL CONTAINER AT CONTROLLED ROOM TEMPERATURE BETWEEN 15-25 DEG C (59-77 DEG F) . SHALL BE MARKED IAW THE LATEST EDITION OF MEDICAL MARKING STANDARD NO. 1 HTTPS://WWW.DLA.MIL/LOGISTICS-OPERATIONS/PACKAGING/ . RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS (IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. . .. RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
PATTERSON VETERINARY SUPPLY, INC. 3G5T7 P/N 07-893-9292 COVETRUS NORTH AMERICA, LLC 4PG41 P/N 071421
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-3550
SECTION B
PR: 7016924071 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016924071 0001 PG 1.000
NSN/MATERIAL:6509017312313
DELIVERY (IN DAYS):0089
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
PARCEL POST ADDRESS:
WK4FV1
W0CC USA MED MAT CTR EUR
SPE2DP-26-T-3550
SECTION B
PR: 7016924071 PRLI: 0001 CONT’D
CMR 469
ATTN CL VIII MED REQ PROCES ACT
APO AE 09227-0000
US
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
WK4FV1
W0CC USA MED MAT CTR EUR
USAMMC E DISTR AND TRANS DIVISION
LUDWIGSHAFENERSTRASSE 31 BLDG 2369
KAISERSLAUTERN 67657
DE
Need Ship Date:00/00/0000 Original Required Delivery Date:05/26/2026
SPE2DP-26-T-3550 NSN/Part Number: 6509-01-731-2313 Quantity: 1 PG Purchase Request: 7016924071QTY: 1 Delivery: 89 days ADO